Show simple item record

dc.contributor.authorWaud, Johnen_US
dc.contributor.authorFeldman, Ellenen_US
dc.contributor.authorSchray, Keithen_US
dc.date.accessioned2006-08-29T18:33:57Zen_US
dc.date.available2006-08-29T18:33:57Zen_US
dc.date.issued1981-02en_US
dc.identifier.citationArchives of Biochemistry and Biophysics 206N2 (1981) 291-295en_US
dc.identifier.issn0003-9861en_US
dc.identifier.urihttp://hdl.handle.net/1850/2562en_US
dc.description.abstractSubstrate analogs xylulose 1,5-bisphosphate, glucitol 1,6-bisphosphate, alpha-2,5-anhydroglucitol 1,6-bisphosphate, alpha-, beta-methyl fructofuranoside 1,6-bisphosphate, ribulose 1,5-bisphosphate, ribulose 5-phosphate, and ribose 5-phosphate and inactivating agents 1-chloro-2, 4-dinitrobenzene, 4-hydroxymercuribenzoate, and pyridoxal phosphate were examined for their effects on liver aldolase. These studies support the use of the beta-anomer and acyclic form as substrate. They also suggest that the liver enzyme active site is similar to the muscle enzyme but with a much weaker 6-phosphate binding site.en_US
dc.description.sponsorshipThis investigation was supported by U. S. Public Health Service Research Grant GM-22378 and a Biomedical Support Grant S07 RR 07173.en_US
dc.format.extent37365 bytesen_US
dc.format.mimetypeapplication/pdfen_US
dc.language.isoen_USen_US
dc.publisherElsevier: Archives of Biochemistry and Biophysicsen_US
dc.subjectInactivationen_US
dc.subjectLiver aldolaseen_US
dc.subjectLiver enzymesen_US
dc.titleInhibition and inactivation of liver aldolaseen_US
dc.typeArticleen_US
dc.identifier.urlhttp://dx.doi.org/10.1016/0003-9861(81)90094-1


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record